Screening breast MR imaging in women with a history of lobular carcinoma in situ

Janice S. Sung, Sharp F. Malak, Punam Bajaj, Rebecca E. Alis, D. David Dershaw, Elizabeth A. Morris

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Purpose: To assess the utility of screening magnetic resonance (MR) imaging in the detection of otherwise occult breast cancers in women with a history of lobular carcinoma in situ (LCIS). Materials and Methods: This HIPAA-compliant study received institutional review board approval. The need for informed consent was waived. Retrospective review of the database yielded 670 screening breast MR studies obtained between January 2003 and September 2008 in 220 women with a history of LCIS. MR and mammographic findings were reviewed. Number of cancers diagnosed, method of detection, and tumor characteristics were examined. The cumulative incidence of developing breast cancer as detected with MR imaging and mammography was calculated. Breast density was examined as a prognostic factor in the cumulative incidence analysis. Results: Biopsy was recommended in 63 lesions seen in 58 (9%) of 670 screening MR studies. Eight additional lesions were identified at short-term follow-up MR imaging for a total of 71 lesions in 59 patients. Twelve cancers (20%) were identified in 60 lesions sampled. Biopsy was recommended in 26 additional lesions identified at mammography; biopsy was performed in 25 of these lesions and revealed malignancy in five (20%). Overall, 17 cancers were detected in 14 patients during the study period. Of these, 12 were detected with MR imaging alone, and five were detected with mammography alone. Of the 12 cancers detected at MR imaging, there were nine invasive cancers and three cases of ductal carcinoma in situ (DCIS). Of the five cancers detected at mammography, two were invasive and three were DCIS. Conclusion: MR imaging is a useful adjunct modality with which to screen women with a history of LCIS at high-risk of developing breast cancer, resulting in a 4.5% incremental cancer detection rate. Sensitivity in the detection of breast cancers with a combination of MR imaging and mammography was higher than sensitivity of either modality alone.

Original languageEnglish (US)
Pages (from-to)414-420
Number of pages7
JournalRadiology
Volume261
Issue number2
DOIs
StatePublished - Nov 2011

Fingerprint

Breast
Magnetic Resonance Imaging
Mammography
Neoplasms
Breast Neoplasms
Carcinoma, Intraductal, Noninfiltrating
Magnetic Resonance Spectroscopy
Biopsy
Health Insurance Portability and Accountability Act
Breast Carcinoma In Situ
Research Ethics Committees
Incidence
Informed Consent
Databases

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Sung, J. S., Malak, S. F., Bajaj, P., Alis, R. E., Dershaw, D. D., & Morris, E. A. (2011). Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology, 261(2), 414-420. https://doi.org/10.1148/radiol.11110091

Screening breast MR imaging in women with a history of lobular carcinoma in situ. / Sung, Janice S.; Malak, Sharp F.; Bajaj, Punam; Alis, Rebecca E.; Dershaw, D. David; Morris, Elizabeth A.

In: Radiology, Vol. 261, No. 2, 11.2011, p. 414-420.

Research output: Contribution to journalArticle

Sung, JS, Malak, SF, Bajaj, P, Alis, RE, Dershaw, DD & Morris, EA 2011, 'Screening breast MR imaging in women with a history of lobular carcinoma in situ', Radiology, vol. 261, no. 2, pp. 414-420. https://doi.org/10.1148/radiol.11110091
Sung, Janice S. ; Malak, Sharp F. ; Bajaj, Punam ; Alis, Rebecca E. ; Dershaw, D. David ; Morris, Elizabeth A. / Screening breast MR imaging in women with a history of lobular carcinoma in situ. In: Radiology. 2011 ; Vol. 261, No. 2. pp. 414-420.
@article{df2ee1c4bbc348c380923e074a8ddeae,
title = "Screening breast MR imaging in women with a history of lobular carcinoma in situ",
abstract = "Purpose: To assess the utility of screening magnetic resonance (MR) imaging in the detection of otherwise occult breast cancers in women with a history of lobular carcinoma in situ (LCIS). Materials and Methods: This HIPAA-compliant study received institutional review board approval. The need for informed consent was waived. Retrospective review of the database yielded 670 screening breast MR studies obtained between January 2003 and September 2008 in 220 women with a history of LCIS. MR and mammographic findings were reviewed. Number of cancers diagnosed, method of detection, and tumor characteristics were examined. The cumulative incidence of developing breast cancer as detected with MR imaging and mammography was calculated. Breast density was examined as a prognostic factor in the cumulative incidence analysis. Results: Biopsy was recommended in 63 lesions seen in 58 (9{\%}) of 670 screening MR studies. Eight additional lesions were identified at short-term follow-up MR imaging for a total of 71 lesions in 59 patients. Twelve cancers (20{\%}) were identified in 60 lesions sampled. Biopsy was recommended in 26 additional lesions identified at mammography; biopsy was performed in 25 of these lesions and revealed malignancy in five (20{\%}). Overall, 17 cancers were detected in 14 patients during the study period. Of these, 12 were detected with MR imaging alone, and five were detected with mammography alone. Of the 12 cancers detected at MR imaging, there were nine invasive cancers and three cases of ductal carcinoma in situ (DCIS). Of the five cancers detected at mammography, two were invasive and three were DCIS. Conclusion: MR imaging is a useful adjunct modality with which to screen women with a history of LCIS at high-risk of developing breast cancer, resulting in a 4.5{\%} incremental cancer detection rate. Sensitivity in the detection of breast cancers with a combination of MR imaging and mammography was higher than sensitivity of either modality alone.",
author = "Sung, {Janice S.} and Malak, {Sharp F.} and Punam Bajaj and Alis, {Rebecca E.} and Dershaw, {D. David} and Morris, {Elizabeth A.}",
year = "2011",
month = "11",
doi = "10.1148/radiol.11110091",
language = "English (US)",
volume = "261",
pages = "414--420",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "2",

}

TY - JOUR

T1 - Screening breast MR imaging in women with a history of lobular carcinoma in situ

AU - Sung, Janice S.

AU - Malak, Sharp F.

AU - Bajaj, Punam

AU - Alis, Rebecca E.

AU - Dershaw, D. David

AU - Morris, Elizabeth A.

PY - 2011/11

Y1 - 2011/11

N2 - Purpose: To assess the utility of screening magnetic resonance (MR) imaging in the detection of otherwise occult breast cancers in women with a history of lobular carcinoma in situ (LCIS). Materials and Methods: This HIPAA-compliant study received institutional review board approval. The need for informed consent was waived. Retrospective review of the database yielded 670 screening breast MR studies obtained between January 2003 and September 2008 in 220 women with a history of LCIS. MR and mammographic findings were reviewed. Number of cancers diagnosed, method of detection, and tumor characteristics were examined. The cumulative incidence of developing breast cancer as detected with MR imaging and mammography was calculated. Breast density was examined as a prognostic factor in the cumulative incidence analysis. Results: Biopsy was recommended in 63 lesions seen in 58 (9%) of 670 screening MR studies. Eight additional lesions were identified at short-term follow-up MR imaging for a total of 71 lesions in 59 patients. Twelve cancers (20%) were identified in 60 lesions sampled. Biopsy was recommended in 26 additional lesions identified at mammography; biopsy was performed in 25 of these lesions and revealed malignancy in five (20%). Overall, 17 cancers were detected in 14 patients during the study period. Of these, 12 were detected with MR imaging alone, and five were detected with mammography alone. Of the 12 cancers detected at MR imaging, there were nine invasive cancers and three cases of ductal carcinoma in situ (DCIS). Of the five cancers detected at mammography, two were invasive and three were DCIS. Conclusion: MR imaging is a useful adjunct modality with which to screen women with a history of LCIS at high-risk of developing breast cancer, resulting in a 4.5% incremental cancer detection rate. Sensitivity in the detection of breast cancers with a combination of MR imaging and mammography was higher than sensitivity of either modality alone.

AB - Purpose: To assess the utility of screening magnetic resonance (MR) imaging in the detection of otherwise occult breast cancers in women with a history of lobular carcinoma in situ (LCIS). Materials and Methods: This HIPAA-compliant study received institutional review board approval. The need for informed consent was waived. Retrospective review of the database yielded 670 screening breast MR studies obtained between January 2003 and September 2008 in 220 women with a history of LCIS. MR and mammographic findings were reviewed. Number of cancers diagnosed, method of detection, and tumor characteristics were examined. The cumulative incidence of developing breast cancer as detected with MR imaging and mammography was calculated. Breast density was examined as a prognostic factor in the cumulative incidence analysis. Results: Biopsy was recommended in 63 lesions seen in 58 (9%) of 670 screening MR studies. Eight additional lesions were identified at short-term follow-up MR imaging for a total of 71 lesions in 59 patients. Twelve cancers (20%) were identified in 60 lesions sampled. Biopsy was recommended in 26 additional lesions identified at mammography; biopsy was performed in 25 of these lesions and revealed malignancy in five (20%). Overall, 17 cancers were detected in 14 patients during the study period. Of these, 12 were detected with MR imaging alone, and five were detected with mammography alone. Of the 12 cancers detected at MR imaging, there were nine invasive cancers and three cases of ductal carcinoma in situ (DCIS). Of the five cancers detected at mammography, two were invasive and three were DCIS. Conclusion: MR imaging is a useful adjunct modality with which to screen women with a history of LCIS at high-risk of developing breast cancer, resulting in a 4.5% incremental cancer detection rate. Sensitivity in the detection of breast cancers with a combination of MR imaging and mammography was higher than sensitivity of either modality alone.

UR - http://www.scopus.com/inward/record.url?scp=80054778306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054778306&partnerID=8YFLogxK

U2 - 10.1148/radiol.11110091

DO - 10.1148/radiol.11110091

M3 - Article

VL - 261

SP - 414

EP - 420

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 2

ER -